{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP04263",
    "Peptide Name": "DP2 (variant of N-15 Cath-2, synthetic AMPs, Arg-rich, UCLL1)",
    "Source": "amino acid substitution, avian cathelicidin analog, animal-derived, natural derivative",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "RFGRFLRKILRFLRK",
    "Sequence Length": 15,
    "UniProt Entry": "Ref",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Anti-Gram+",
      "Gram-"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "Helix",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": 7,
    "Boman Index": 3.74,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "47%",
    "Crucial residues": ""
  },
  "Literature Information": {
    "Literature": "Sequence analysis: APD analysis reveals that this sequence is most similar (93.33%) toDP1R: 33%, L=F: 20%, K: 13%.Activity: active against Gram- E. coli O175:H7 (MIC 8 ug/ml), S. typhimurium NCTC 74 (MIC 32 ug/ml), and Gram+ S. aureus ATCC 9155 (MIC 32 ug/ml).Toxicity: murine RBC:  HC50 145 ug/ml, less hemo.lytic.Structure:  became helical in 50% TFE.",
    "Author": "Sharma P, Sharma S, Joshi S, Barman P, Bhatt A, Maan M, Singla N, Rishi P, Ali ME, Preet S, Saini A.2022",
    "Reference": "Sci Rep. 2022 Jul 14;12(1):12058. doi: 10.1038/s41598-022-16303-2.PubMed",
    "Title": "Design, characterization and structure-function analysis of novel antimicrobial peptides based on the N-terminal CATH-2 fragment."
  },
  "3D Structure": []
}